ITRM20020014A0 - Derivati di acidi a-feniltiocarbossilici e a-fenilossicarbossilici utili per il trattamento di patologie che rispondono all'attivazione del - Google Patents
Derivati di acidi a-feniltiocarbossilici e a-fenilossicarbossilici utili per il trattamento di patologie che rispondono all'attivazione delInfo
- Publication number
- ITRM20020014A0 ITRM20020014A0 IT2002RM000014A ITRM20020014A ITRM20020014A0 IT RM20020014 A0 ITRM20020014 A0 IT RM20020014A0 IT 2002RM000014 A IT2002RM000014 A IT 2002RM000014A IT RM20020014 A ITRM20020014 A IT RM20020014A IT RM20020014 A0 ITRM20020014 A0 IT RM20020014A0
- Authority
- IT
- Italy
- Prior art keywords
- phenylthiocarboxylic
- respond
- diseases
- activation
- derivatives
- Prior art date
Links
- 239000002253 acid Substances 0.000 title 1
- 150000007513 acids Chemical class 0.000 title 1
- 230000004913 activation Effects 0.000 title 1
- 201000010099 disease Diseases 0.000 title 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
- C07C323/50—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton
- C07C323/51—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton
- C07C323/52—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being acyclic and saturated
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
- C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D307/38—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D307/40—Radicals substituted by oxygen atoms
- C07D307/42—Singly bound oxygen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
- C07C69/66—Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety
- C07C69/67—Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety of saturated acids
- C07C69/708—Ethers
- C07C69/712—Ethers the hydroxy group of the ester being etherified with a hydroxy compound having the hydroxy group bound to a carbon atom of a six-membered aromatic ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/08—Indoles; Hydrogenated indoles with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to carbon atoms of the hetero ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/56—Ring systems containing three or more rings
- C07D209/80—[b, c]- or [b, d]-condensed
- C07D209/82—Carbazoles; Hydrogenated carbazoles
- C07D209/86—Carbazoles; Hydrogenated carbazoles with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the ring system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
- C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D307/56—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D307/68—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Hematology (AREA)
- Vascular Medicine (AREA)
- Hospice & Palliative Care (AREA)
- Diabetes (AREA)
- Urology & Nephrology (AREA)
- Obesity (AREA)
- Emergency Medicine (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Furan Compounds (AREA)
- Indole Compounds (AREA)
Priority Applications (18)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IT2002RM000014A ITRM20020014A1 (it) | 2002-01-15 | 2002-01-15 | Derivati di acidi a-feniltiocarbossilici e a-fenilossicarbossilici utili per il trattamento di patologie che rispondono all'attivazione del |
PCT/IT2003/000011 WO2003059875A2 (en) | 2002-01-15 | 2003-01-15 | DERIVATIVES OF α-PHENYLTHIOCARBOXYLIC AND α-PHENYLOXY-CARBOXYLIC ACIDS USEFUL FOR THE TREATMENT OF DISEASES RESPONDING TO PPARα ACTIVATION |
CNB038022893A CN100522940C (zh) | 2002-01-15 | 2003-01-15 | 用于治疗对PPARα活化有反应的疾病的α-苯硫基羧酸和α-苯氧基-羧酸的衍生物 |
JP2003559979A JP2005514456A (ja) | 2002-01-15 | 2003-01-15 | PPARα活性化に応答する疾患の治療に有用なα−フェニルチオカルボン酸およびα−フェニルオキシカルボン酸の誘導体 |
US10/501,472 US20050054671A1 (en) | 2002-01-15 | 2003-01-15 | Derivatives of alpha-phenylthiocarboxylic and $g(a)-phenyloxy-carboxylic acids useful for the treatment of diseases responding to pparalpha activation |
KR1020047010634A KR100975961B1 (ko) | 2002-01-15 | 2003-01-15 | PPARα활성화에 반응하는 질병의 치료에 유용한α-페닐티오카르복시산 및$G(a)-페닐옥시-카르복시산의 유도체 |
CA002472223A CA2472223A1 (en) | 2002-01-15 | 2003-01-15 | Derivatives of alpha-phenylthiocarboxylic and alpha-phenyloxy-carboxylic acids useful for the treatment of diseases responding to pparalpha activation |
ARP030100103A AR038146A1 (es) | 2002-01-15 | 2003-01-15 | Derivados de acidos alfa-feniltiocarboxilico y alfa-feniloxi-carboxilico util para el tratamiento de enfermedades que responden a la activacion de pparalfa |
TW092101061A TW200305410A (en) | 2002-01-15 | 2003-01-15 | Derivatives of α -phenylthiocarboxylic and α -phenyloxycarboxylic acids useful for the treatment of diseases responding to PRAR α activation |
PL03372666A PL372666A1 (en) | 2002-01-15 | 2003-01-15 | Derivatives of alpha-phenylthiocarboxylic and alpha-phenyloxy-carboxylic acids useful for the treatment of diseases responding to ppar alpha activation |
AT03729547T ATE489361T1 (de) | 2002-01-15 | 2003-01-15 | Derivate von alpha-phenylthiocarbon- und alpha- phenyloxycarbonsäuren, die für die behandlung von auf die aktivierung von ppar alpha ansprechende krankheiten geeignet sind |
BR0306824-2A BR0306824A (pt) | 2002-01-15 | 2003-01-15 | Derivados de ácidos alfa-feniltiocarboxìlico e alfa-fenilóxi-carboxìlico úteis para o tratamento de doenças respondendo à ativação de pparalfa |
EP03729547A EP1474387B1 (en) | 2002-01-15 | 2003-01-15 | Derivatives of alpha-phenylthiocarboxylic and alpha-phenyloxy-carboxylic acids useful for the treatment of diseases responding to ppar alpha activation |
AU2003209679A AU2003209679B2 (en) | 2002-01-15 | 2003-01-15 | Derivatives of alpha-phenylthiocarboxylic and alpha-phenyloxy-carboxylic acids useful for the treatment of diseases responding to PPARalpha activation |
MXPA04006803A MXPA04006803A (es) | 2002-01-15 | 2003-01-15 | Derivados de acidos alfa-feniltiocarboxilicos y alfa-feniloxi-carboxilicos para tratamiento de enfermedades que responden a activacion del receptor alfa activado del proliferador de peroxisoma. |
DE60335083T DE60335083D1 (de) | 2002-01-15 | 2003-01-15 | Derivate von alpha-phenylthiocarbon- und alpha-phenyloxycarbonsäuren, die für die behandlung von auf die aktivierung von ppar alpha ansprechende krankheiten geeignet sind |
HK05108606.4A HK1076625A1 (en) | 2002-01-15 | 2005-09-29 | Derivatives of a-phenylthiocarboxylic and sg(a)-phenyloxy-carboxylic acids useful for the treatment of diseases responding to ppara activation |
US11/889,930 US20080027098A1 (en) | 2002-01-15 | 2007-08-17 | Derivatives of alpha-phenylthiocarboxylic and alpha-phenyloxy-carboxylic acids useful for the treatment of diseases responding to PPARalpha activation |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IT2002RM000014A ITRM20020014A1 (it) | 2002-01-15 | 2002-01-15 | Derivati di acidi a-feniltiocarbossilici e a-fenilossicarbossilici utili per il trattamento di patologie che rispondono all'attivazione del |
Publications (2)
Publication Number | Publication Date |
---|---|
ITRM20020014A0 true ITRM20020014A0 (it) | 2002-01-15 |
ITRM20020014A1 ITRM20020014A1 (it) | 2003-07-15 |
Family
ID=11455954
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IT2002RM000014A ITRM20020014A1 (it) | 2002-01-15 | 2002-01-15 | Derivati di acidi a-feniltiocarbossilici e a-fenilossicarbossilici utili per il trattamento di patologie che rispondono all'attivazione del |
Country Status (17)
Country | Link |
---|---|
US (2) | US20050054671A1 (it) |
EP (1) | EP1474387B1 (it) |
JP (1) | JP2005514456A (it) |
KR (1) | KR100975961B1 (it) |
CN (1) | CN100522940C (it) |
AR (1) | AR038146A1 (it) |
AT (1) | ATE489361T1 (it) |
AU (1) | AU2003209679B2 (it) |
BR (1) | BR0306824A (it) |
CA (1) | CA2472223A1 (it) |
DE (1) | DE60335083D1 (it) |
HK (1) | HK1076625A1 (it) |
IT (1) | ITRM20020014A1 (it) |
MX (1) | MXPA04006803A (it) |
PL (1) | PL372666A1 (it) |
TW (1) | TW200305410A (it) |
WO (1) | WO2003059875A2 (it) |
Families Citing this family (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2004022551A1 (ja) * | 2002-09-06 | 2004-03-18 | Takeda Pharmaceutical Company Limited | フランまたはチオフェン誘導体およびその医薬用途 |
ITRM20020629A1 (it) | 2002-12-19 | 2004-06-20 | Sigma Tau Ind Farmaceuti | Uso di acidi alfa-feniltiocarbossilici e alfa-fenilossicarbossilici ad attivita' ipoglicemizzante e/o ipolipidemizzante. |
ES2328581T3 (es) | 2003-09-19 | 2009-11-16 | Janssen Pharmaceutica Nv | Acidos 4-((fhenoxialquil)tio)-fenoxiaceticos y analogos. |
CN1867546A (zh) * | 2003-10-28 | 2006-11-22 | 雷迪实验室有限公司 | 新颖化合物及其在药物中的用途、其制备方法以及含有它们的药物组合物 |
NZ552501A (en) | 2004-08-11 | 2010-03-26 | Kyorin Seiyaku Kk | Novel cyclic aminobenzoic acid derivative |
MY147518A (en) * | 2004-09-15 | 2012-12-31 | Janssen Pharmaceutica Nv | 4-((phenoxyalkyl)thio)-phenoxyacetic acids and analogs |
FR2880886B1 (fr) * | 2005-01-14 | 2007-04-06 | Merck Sante Soc Par Actions Si | Derives de l'acide 6-phenylhex-5-enoique, procedes pour leur preparation, compositions pharmaceutiques les contenant et applications en therapeutique |
WO2006082495A1 (en) * | 2005-02-02 | 2006-08-10 | Ranbaxy Laboratories Limited | Peroxisome proliferator activated receptor modulators |
FR2882359A1 (fr) * | 2005-02-24 | 2006-08-25 | Negma Lerads Soc Par Actions S | Derives activateurs de ppar, procede de preparation et application en therapeutique |
CN101189231B (zh) * | 2005-03-23 | 2011-05-18 | 杏林制药株式会社 | 环状氨基苯基链烷酸衍生物 |
JO3006B1 (ar) | 2005-09-14 | 2016-09-05 | Janssen Pharmaceutica Nv | املاح ليسين مبتكرة من مشتقات حامض 4-((فينوكسي الكيل)ثيو) فينوكسي الخليك |
PE20080188A1 (es) | 2006-04-18 | 2008-03-10 | Janssen Pharmaceutica Nv | Derivados del acido benzoazepin-oxi-acetico como agonistas de ppar-delta usados para aumentar hdl-c, reducir ldl-c y reducir colesterol |
WO2008014430A1 (en) | 2006-07-27 | 2008-01-31 | Emisphere Technologies, Inc. | Arylsulfanyl compounds and compositions for delivering active agents |
JP5305818B2 (ja) * | 2008-10-03 | 2013-10-02 | キヤノン株式会社 | 生体情報取得装置 |
JP5669889B2 (ja) * | 2013-06-27 | 2015-02-18 | キヤノン株式会社 | 生体情報取得装置 |
CN106179111B (zh) * | 2016-07-16 | 2018-08-14 | 江南大学 | 一种由羧酸盐阴离子表面活性剂和二聚季铵盐形成的粘弹溶液 |
Family Cites Families (23)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB1121722A (en) * | 1966-03-31 | 1968-07-31 | Ici Ltd | New carboxylic acid derivatives |
US3663540A (en) * | 1970-06-19 | 1972-05-16 | R & L Molecular Research Ltd | 7 - (p-aminomethylphenylthio)acetamido-3 -(pyridiniummethyl)ceph - 3 - em - 4-carboxylate |
US3965093A (en) * | 1971-09-24 | 1976-06-22 | E. R. Squibb & Sons, Inc. | 6-Arylthio penicillanic acid and derivatives thereof |
GB1422679A (en) * | 1972-11-16 | 1976-01-28 | Funai Pharmaceutical Ind Ltd | Substituted phenoxy-a-methylpropionic acid derivatives and a process for producing the same |
FR2285859A1 (fr) * | 1974-09-30 | 1976-04-23 | Lafon Labor | Phenylsulfinyl-amidines et derives |
EP0000359B1 (de) * | 1977-07-07 | 1981-10-21 | Ciba-Geigy Ag | Phenoxy-phenylsulfinyl- und -sulfonyl-alkancarbonsäure-Derivate, Verfahren zu deren Herstellung und deren Verwendung als Herbizide und als Pflanzenwachstumsregulierungsmittel. |
JPH0311045A (ja) * | 1989-06-08 | 1991-01-18 | Hodogaya Chem Co Ltd | ベンズアミド誘導体 |
JPH06234732A (ja) * | 1992-09-10 | 1994-08-23 | Banyu Pharmaceut Co Ltd | 置換アセトアミド誘導体 |
FR2700166B1 (fr) * | 1993-01-07 | 1995-02-17 | Rhone Poulenc Rorer Sa | Dérivés de pyrrolidine, leur préparation et les médicaments les contenant. |
JP3583529B2 (ja) * | 1995-12-04 | 2004-11-04 | 富士写真フイルム株式会社 | ハロゲン化銀感光材料 |
CA2245524A1 (en) * | 1996-02-02 | 1997-08-07 | Wei Han | Antidiabetic agents |
EP0930882A2 (en) | 1996-08-02 | 1999-07-28 | Institut Pasteur De Lille | Prevention or treatment of type 2 diabetes or cardiovascular disease with ppar modulators |
US6197791B1 (en) * | 1997-02-27 | 2001-03-06 | American Cyanamid Company | N-hdroxy-2-(alkyl, aryl, or heteroaryl, sulfanyl, sulfinyl or sulfonyl)-3-substituted alkyl, aryl or heteroarylamides as matrix metalloproteinase inhibitors |
US6294573B1 (en) * | 1997-08-06 | 2001-09-25 | Abbott Laboratories | Reverse hydroxamate inhibitors of matrix metalloproteinases |
KR100414336B1 (ko) * | 1998-06-22 | 2004-01-07 | 바실리어 파마슈티카 아게 | 프로페닐 세팔로스포린 유도체 |
JP4618845B2 (ja) * | 1999-06-09 | 2011-01-26 | 杏林製薬株式会社 | ヒトペルオキシゾーム増殖薬活性化受容体(PPAR)αアゴニストとしての置換フェニルプロピオン酸誘導体 |
DE19940415A1 (de) * | 1999-08-26 | 2001-03-08 | Friedrich Spener | Verzweigtkettige Fettsäuren als fettabbauende Wirkstoffe |
US6525093B1 (en) * | 1999-11-08 | 2003-02-25 | Calyx Therapeutics Inc. | Compounds to treat diabetes and associated conditions |
CN1396904A (zh) * | 2000-01-28 | 2003-02-12 | 诺沃挪第克公司 | 新颖的化合物、它们的制备和用途 |
WO2001079150A1 (en) * | 2000-04-17 | 2001-10-25 | Novo Nordisk A/S | New compounds, their preparation and use |
ATE407919T1 (de) * | 2000-05-29 | 2008-09-15 | Kyorin Seiyaku Kk | Substituierte phenylpropionsäure-derivate |
US6982278B2 (en) * | 2000-08-23 | 2006-01-03 | Eli Lilly And Company | Oxazolyl-aryloxyacetic acid derivatives and their use as ppar agonists |
GB0111523D0 (en) * | 2001-05-11 | 2001-07-04 | Glaxo Group Ltd | Chemical compounds |
-
2002
- 2002-01-15 IT IT2002RM000014A patent/ITRM20020014A1/it unknown
-
2003
- 2003-01-15 PL PL03372666A patent/PL372666A1/xx unknown
- 2003-01-15 MX MXPA04006803A patent/MXPA04006803A/es active IP Right Grant
- 2003-01-15 JP JP2003559979A patent/JP2005514456A/ja active Pending
- 2003-01-15 DE DE60335083T patent/DE60335083D1/de not_active Expired - Lifetime
- 2003-01-15 EP EP03729547A patent/EP1474387B1/en not_active Expired - Lifetime
- 2003-01-15 WO PCT/IT2003/000011 patent/WO2003059875A2/en active Application Filing
- 2003-01-15 KR KR1020047010634A patent/KR100975961B1/ko not_active IP Right Cessation
- 2003-01-15 AR ARP030100103A patent/AR038146A1/es unknown
- 2003-01-15 AT AT03729547T patent/ATE489361T1/de not_active IP Right Cessation
- 2003-01-15 CA CA002472223A patent/CA2472223A1/en not_active Abandoned
- 2003-01-15 AU AU2003209679A patent/AU2003209679B2/en not_active Ceased
- 2003-01-15 TW TW092101061A patent/TW200305410A/zh unknown
- 2003-01-15 US US10/501,472 patent/US20050054671A1/en not_active Abandoned
- 2003-01-15 BR BR0306824-2A patent/BR0306824A/pt not_active IP Right Cessation
- 2003-01-15 CN CNB038022893A patent/CN100522940C/zh not_active Expired - Fee Related
-
2005
- 2005-09-29 HK HK05108606.4A patent/HK1076625A1/xx not_active IP Right Cessation
-
2007
- 2007-08-17 US US11/889,930 patent/US20080027098A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
WO2003059875A2 (en) | 2003-07-24 |
WO2003059875A3 (en) | 2003-12-04 |
EP1474387A2 (en) | 2004-11-10 |
JP2005514456A (ja) | 2005-05-19 |
DE60335083D1 (de) | 2011-01-05 |
BR0306824A (pt) | 2004-12-21 |
ITRM20020014A1 (it) | 2003-07-15 |
CN100522940C (zh) | 2009-08-05 |
EP1474387B1 (en) | 2010-11-24 |
HK1076625A1 (en) | 2006-01-20 |
MXPA04006803A (es) | 2004-10-11 |
AU2003209679A1 (en) | 2003-07-30 |
AU2003209679B2 (en) | 2009-02-19 |
CA2472223A1 (en) | 2003-07-24 |
AR038146A1 (es) | 2004-12-29 |
US20080027098A1 (en) | 2008-01-31 |
PL372666A1 (en) | 2005-07-25 |
KR100975961B1 (ko) | 2010-08-16 |
US20050054671A1 (en) | 2005-03-10 |
ATE489361T1 (de) | 2010-12-15 |
TW200305410A (en) | 2003-11-01 |
CN1620429A (zh) | 2005-05-25 |
KR20040068996A (ko) | 2004-08-02 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE60043692D1 (de) | Acyl derivate zur behandlung von krankheiten die in zusammenhang mit vla-4 stehen | |
ITRM20020014A1 (it) | Derivati di acidi a-feniltiocarbossilici e a-fenilossicarbossilici utili per il trattamento di patologie che rispondono all'attivazione del | |
ATE512163T1 (de) | Verabreichung von mitteln zur behandlung von entzündungen | |
DE60031710D1 (de) | Fettsäurederivat zur behandlung von externen sekretionsstörungen | |
ATE380809T1 (de) | Trisubstituiertes aryl- und heteroarylderivate als stoffwechselmodulatoren und die prophylaxe und behandlung von damit in zusammenhang stehenden erkrankungen | |
ATE432072T1 (de) | Verwendung von adapalen zur behandlung dermatologischer erkrankungen | |
DE60124302D1 (de) | Thiazolderivate zur behandlung von ppar-lierte krankheiten | |
DE60319865D1 (de) | Substituierte amin-derivate und deren verwendung zur behandlung von angionese-bedingten erkrankungen | |
ATE516037T1 (de) | Topische formulierung von ivermectin zur behandlung von dermatologischen erkrankungen | |
ATE429922T1 (de) | Topische gel-abgabesysteme zur behandlung von hauterkrankungen | |
DE60335560D1 (de) | Zusammensetzungen enthaltend zitronensäure zur behandlung von nagelpilzerkrankungen | |
DE60036968D1 (de) | Adamantanderivate zur Behandlung von entzündlichen, immunologischen und kardiovaskulären Erkrankungen | |
CY1108932T1 (el) | Ενωσεις 4-(ετεροκυκλυλ)-βενζολοσουλφοξιμινης για την θεραπευτικη αγωγη φλεγμονωδων ασθενειων | |
DE602004019206D1 (de) | Entzündungshemmende arzneizubereitungen zur entzündungsverminderung und die therapie oder die prophylaxe von der gastrischen toxizität | |
DE60318839D1 (de) | 2,6-chinolinyl- und 2,6-naphthylderivate und deren verwendungen zur behandlung von vla-4 bezogenen krankheiten | |
ATE295174T1 (de) | Arzneimittel zur behandlung von bluthochdruck | |
ITMI20010957A0 (it) | Derivati dell'aoe-emodina e loro impiego nel trattamento di patologieneoplastiche | |
ATE345123T1 (de) | Behandlung von angiogenesebezogenen krankheiten mit benzoyl phenylessigsäure derivaten | |
DE60314003D1 (de) | 4-(phenylpiperazinylmethyl)benzamidderivate und deren verwendung zur behandlung von schmerzen oder gastrointestinalen erkrankungen | |
ATE289196T1 (de) | Verwendung von pleuromutilinderivaten zur transdermalen behandlung bakterieller erkrankungen | |
ATE330596T1 (de) | Verwendung von 3-bezoylphenylessigsäure-derivaten zur behandlung von netzhauterkrankungen | |
ATE330938T1 (de) | Disulfid-derivate verwendbar zur behandlung von allergischen erkrankungen | |
DE60043648D1 (de) | Medikamente zur behandlung von periodontalen erkrankungen | |
DE60313208D1 (de) | Phenyl-piperidin-4-yliden-methyl-benzamidderivate zur behandlung von schmerz oder magen-darm-erkrankungen | |
DE50011654D1 (de) | Superfizielles therapeutisches system zur topischen applikation von acetylsalicylsäure zur behandlung von akne-erkrankungen |